Gamida Cell

Cancer Therapy

Gamida Cell is a biopharmaceutical company developing advanced cell therapies to treat blood cancers and other rare hematologic diseases.

Gamida Cell’s proprietary nicotinamide (NAM) technology is a culture method that helps deliver cell therapies with enhanced functionality, leading to better clinical outcomes. Their allogenic therapies include stem cells with improved homing and retention as well as natural killer (NK) cells with increased resistance to oxidative stress.

SECTOR

Health Sciences

INVESTED

2017

STATUS

NASDQ: GMDA

HQ

Boston, MA

FOUNDERS

Prof. Tony Peled
Prof. Shai Yarkoni

Visit The Site

Gamida Cell

Cancer Therapy

SECTOR

INVESTED

STATUS

HQ

FOUNDERS

Subscribe to hear about Arc Ventures' updates and events.

Make the Connection.

ARC VENTURES